Older patients with IBD at higher risk for thiopurine-related adverse events

Among patients with inflammatory bowel disease older than 60 years, thiopurines were associated with an increased risk for non-infectious and non-neoplastic adverse events, according to study results.
Míriam Mañosa, of the IBD Unit at Hospital Universitari Germans Trias i Pujol in Spain, and colleagues wrote that starting immunosuppressant therapy in older patients with IBD can be difficult because of the associated comorbidities and polypharmacy.
“Physiological changes in the elderly patients may impact the pharmacokinetics of orally administered drugs,” they wrote in

Source link

Related posts

Transplantation of HCV-Infected Kidneys into Uninfected Patients


Symptom severity, mood linked with patient satisfaction in IBS


Readout-segmented echo-planar diffusion-weighted MR for the evaluation of aggressive characteristics of rectal cancer


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy